171 related articles for article (PubMed ID: 12055235)
1. Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death.
Li L; Qi X; Williams M; Shi Y; Keegan AD
J Immunol; 2002 Jun; 168(12):6215-23. PubMed ID: 12055235
[TBL] [Abstract][Full Text] [Related]
2. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
Zhong L; Wu CH; Lee WH; Liu CP
J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
Delgado M; Ganea D
J Immunol; 2000 Feb; 164(3):1200-10. PubMed ID: 10640731
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor substrates 1 and 2 but not Shc can activate the insulin receptor independent of insulin and induce proliferation in CHO-IR cells.
Niessen M; Jaschinski F; Item F; McNamara MP; Spinas GA; Trüb T
Exp Cell Res; 2007 Feb; 313(4):805-15. PubMed ID: 17222824
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
7. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
Zhang J; Gao JX; Salojin K; Shao Q; Grattan M; Meagher C; Laird DW; Delovitch TL
J Exp Med; 2000 Mar; 191(6):1017-30. PubMed ID: 10727463
[TBL] [Abstract][Full Text] [Related]
8. SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin.
Duan C; Li M; Rui L
J Biol Chem; 2004 Oct; 279(42):43684-91. PubMed ID: 15316008
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.
Kawaguchi T; Yoshida T; Harada M; Hisamoto T; Nagao Y; Ide T; Taniguchi E; Kumemura H; Hanada S; Maeyama M; Baba S; Koga H; Kumashiro R; Ueno T; Ogata H; Yoshimura A; Sata M
Am J Pathol; 2004 Nov; 165(5):1499-508. PubMed ID: 15509521
[TBL] [Abstract][Full Text] [Related]
10. Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function.
Cui H; Sherr DH; el-Khatib M; Matsui K; Panka DJ; Marshak-Rothstein A; Ju ST
Cell Immunol; 1996 Feb; 167(2):276-84. PubMed ID: 8603437
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells.
Tanimoto Y; Kizaki H
J Biochem; 2002 Mar; 131(3):319-26. PubMed ID: 11872160
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation.
Wang R; Zhang L; Zhang X; Moreno J; Luo X; Tondravi M; Shi Y
J Immunol; 2001 Feb; 166(3):1983-90. PubMed ID: 11160247
[TBL] [Abstract][Full Text] [Related]
13. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
Guo S; Dunn SL; White MF
Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
[TBL] [Abstract][Full Text] [Related]
14. Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption.
Zheng Y; Yamada H; Sakamoto K; Horita S; Kunimi M; Endo Y; Li Y; Tobe K; Terauchi Y; Kadowaki T; Seki G; Fujita T
J Am Soc Nephrol; 2005 Aug; 16(8):2288-95. PubMed ID: 15975995
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
[TBL] [Abstract][Full Text] [Related]
16. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death.
Park CG; Lee SY; Kandala G; Lee SY; Choi Y
Immunity; 1996 Jun; 4(6):583-91. PubMed ID: 8673705
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation.
Cui H; el-Khatib M; Sherr DH; Ettinger R; Sy MS; Marshak-Rothstein A; Ju ST
Cell Immunol; 1996 Feb; 167(2):302-12. PubMed ID: 8603440
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of Fas-mediated cytotoxicity and FasL expression in a cytotoxic CD4+ T-cell clone. Comparative analysis of Fas-mediated cytotoxicity between a T-hybridoma and a T-cell clone.
Kaneda R; Iwabuchi K; Onoé K
Immunol Lett; 1997 Jan; 55(1):53-60. PubMed ID: 9093882
[TBL] [Abstract][Full Text] [Related]
19. Protection of T cells from activation-induced cell death by Fas+ B cells.
Wang JK; Ju ST; Marshak-Rothstein A
Eur J Immunol; 2000 Mar; 30(3):931-7. PubMed ID: 10741411
[TBL] [Abstract][Full Text] [Related]
20. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas.
Williams MS; Henkart PA
J Immunol; 1996 Sep; 157(6):2395-402. PubMed ID: 8805638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
